Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results

Zilli, Thomas; Jorcano, Sandra; Bral, Samuel; Rubio, Carmen; Bruynzeel, Anna M.E.; Oliveira, Angelo; Abacioglu, Ufuk; Minn, Heikki; Symon, Zvi; Miralbell, Raymond

doi:10.1002/cam4.2966

Scientific article

English

Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results

ContributorsZilli, Thomas; Jorcano, Sandra; Bral, Samuel; Rubio, Carmen; Bruynzeel, Anna M.E.; Oliveira, Angelo; Abacioglu, Ufuk; Minn, Heikki; Symon, Zvi; Miralbell, Raymond

Published inCancer Medicine

Publication date2020

Abstract

To present the 18 months results from a prospective multicenter phase II randomized trial of short vs protracted urethra‐sparing stereotactic body radiotherapy (SBRT) for localized prostate cancer (PCa).

Keywords

Overall treatment time
Prostate cancer
Quality of life
Stereotactic body radiotherapy
Urethra sparing

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale

Research groups

Laboratoire de radiothérapie de haute précision pour le cancer de la prostate (1014)

Citation (ISO format)

ZILLI, Thomas et al. Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results. In: Cancer Medicine, 2020. doi: 10.1002/cam4.2966

Article (Published version)

CC BY

Identifiers

PID : unige:135380
DOI : 10.1002/cam4.2966
PMID : 32160416

Additional URL for this publicationhttps://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.2966

Journal ISSN2045-7634

302views

571downloads

Creation28/04/2020 17:24:00

First validation28/04/2020 17:24:00

Update15/03/2023 21:51:35

Status update15/03/2023 21:51:34

Last indexation31/10/2024 18:32:34

Archive ouverte UNIGE

Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results

To present the 18 months results from a prospective multicenter phase II randomized trial of short vs protracted urethra‐sparing stereotactic body radiotherapy (SBRT) for localized prostate cancer (PCa).

Technical informations